News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Pease Flavia
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2023 |
4
| Pease Flavia (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,215 shares
@ $0
Paid exercise price by delivering 137 shares
@ $194.12, valued at
$26.6k
Granted 5,314 options to buy
@ $194.12, valued at
$1M
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Pease Flavia (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 5,185 shares
@ $0
Granted 4,649 options to buy
@ $245.88, valued at
$1.1M
|
|
| 04/26/2022 |
3
| Pease Flavia (Corporate Executive VP) has filed a Form 3 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|
|